Neogen Days Sales Outstanding vs Price To Sales Ratio Analysis

NEOG Stock

USD 11.56 0.04 0.34%

Neogen financial indicator trend analysis is infinitely more than just investigating Neogen recent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Neogen is a good investment. Please check the relationship between Neogen Days Sales Outstanding and its Price To Sales Ratio accounts. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Neogen. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons.

For more detail on how to invest in Neogen Stock please use our How to Invest in Neogen guide.

Days Sales Outstanding vs Price To Sales Ratio

Days Sales Outstanding vs Price To Sales Ratio Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Neogen Days Sales Outstanding account and Price To Sales Ratio. At this time, the significance of the direction appears to have strong relationship.

The correlation between Neogen's Days Sales Outstanding and Price To Sales Ratio is 0.64. Overlapping area represents the amount of variation of Days Sales Outstanding that can explain the historical movement of Price To Sales Ratio in the same time period over historical financial statements of Neogen, assuming nothing else is changed. The correlation between historical values of Neogen's Days Sales Outstanding and Price To Sales Ratio is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Days Sales Outstanding of Neogen are associated (or correlated) with its Price To Sales Ratio. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Price To Sales Ratio has no effect on the direction of Days Sales Outstanding i.e., Neogen's Days Sales Outstanding and Price To Sales Ratio go up and down completely randomly.

Correlation Coefficient

0.64

Relationship Direction	Positive
Relationship Strength	Significant

View All Relationships

Days Sales Outstanding

Price To Sales Ratio

Price to Sales Ratio is figured by comparing Neogen stock price to its revenues. An advantage to using Price to Sales ratio is that it is based on Neogen sales, a figure that is much harder to manipulate than other Neogen multiples. Because sales tend to be more stable P/S ratio can be a good tool for screening cyclical companies fluctuating earnings patterns. A valuation ratio that compares a company's stock price to its revenues, calculated by dividing the company's market cap by its total sales or revenue over a 12-month period.

Most indicators from Neogen's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Neogen current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Neogen. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons.

For more detail on how to invest in Neogen Stock please use our How to Invest in Neogen guide.At this time, Neogen's Selling General Administrative is most likely to increase significantly in the upcoming years. The Neogen's current Enterprise Value is estimated to increase to about 3.4 B, while Tax Provision is forecasted to increase to (4.2 M).

	2022	2023	2024	2025 (projected)
Gross Profit	406.0M	463.9M	533.5M	560.2M
Total Revenue	822.4M	924.2M	1.1B	1.1B

Gross Profit Total Revenue

Neogen fundamental ratios Correlations

	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Property Plant And Equipment Net	Net Debt	Retained Earnings	Cash	Non Current Assets Total	Non Currrent Assets Other	Cash And Short Term Investments	Net Receivables	Common Stock Shares Outstanding	Non Current Liabilities Total	Inventory	Other Current Assets	Other Stockholder Equity	Total Liab	Property Plant And Equipment Gross	Total Current Assets	Short Term Debt	Intangible Assets	Accounts Payable	Common Stock Total Equity	Short Term Investments
Total Assets		0.88	0.95	0.99	1.0	0.97	0.88	0.76	0.14	1.0	-0.13	0.21	0.95	0.96	0.99	0.92	0.92	1.0	1.0	0.97	0.74	0.91	1.0	0.99	0.98	-0.31
Short Long Term Debt Total	0.88		0.92	0.92	0.89	0.88	0.97	0.77	0.26	0.87	-0.19	0.32	0.86	0.83	0.86	0.87	0.94	0.87	0.87	0.93	0.75	0.8	0.87	0.91	0.91	-0.11
Other Current Liab	0.95	0.92		0.98	0.96	0.94	0.85	0.9	0.4	0.92	-0.1	0.47	0.97	0.92	0.91	0.95	0.97	0.93	0.92	0.95	0.89	0.79	0.92	0.97	0.98	-0.03
Total Current Liabilities	0.99	0.92	0.98		0.99	0.99	0.89	0.84	0.27	0.97	-0.12	0.33	0.98	0.96	0.96	0.97	0.96	0.98	0.97	0.99	0.83	0.89	0.97	1.0	0.99	-0.19
Total Stockholder Equity	1.0	0.89	0.96	0.99		0.98	0.87	0.79	0.18	0.99	-0.13	0.25	0.96	0.96	0.99	0.94	0.93	0.99	0.99	0.98	0.77	0.9	0.99	1.0	0.99	-0.27
Property Plant And Equipment Net	0.97	0.88	0.94	0.99	0.98		0.85	0.81	0.25	0.96	-0.11	0.28	0.98	0.97	0.95	0.98	0.93	0.97	0.96	0.99	0.8	0.94	0.95	0.99	0.98	-0.23
Net Debt	0.88	0.97	0.85	0.89	0.87	0.85		0.61	0.02	0.88	-0.18	0.09	0.8	0.81	0.88	0.79	0.87	0.88	0.89	0.91	0.59	0.83	0.89	0.88	0.87	-0.33
Retained Earnings	0.76	0.77	0.9	0.84	0.79	0.81	0.61		0.74	0.7	-0.09	0.78	0.9	0.79	0.67	0.91	0.89	0.71	0.69	0.81	1.0	0.58	0.69	0.81	0.84	0.35
Cash	0.14	0.26	0.4	0.27	0.18	0.25	0.02	0.74		0.06	-0.09	0.98	0.38	0.2	0.02	0.43	0.43	0.08	0.05	0.24	0.76	-0.03	0.05	0.23	0.29	0.87
Non Current Assets Total	1.0	0.87	0.92	0.97	0.99	0.96	0.88	0.7	0.06		-0.13	0.13	0.93	0.95	1.0	0.89	0.89	1.0	1.0	0.96	0.69	0.92	1.0	0.98	0.97	-0.38
Non Currrent Assets Other	-0.13	-0.19	-0.1	-0.12	-0.13	-0.11	-0.18	-0.09	-0.09	-0.13		-0.1	-0.06	-0.07	-0.13	-0.09	-0.22	-0.13	-0.13	-0.14	-0.11	-0.14	-0.13	-0.12	-0.15	-0.13
Cash And Short Term Investments	0.21	0.32	0.47	0.33	0.25	0.28	0.09	0.78	0.98	0.13	-0.1		0.42	0.25	0.1	0.45	0.48	0.15	0.12	0.28	0.8	-0.02	0.12	0.29	0.35	0.85
Net Receivables	0.95	0.86	0.97	0.98	0.96	0.98	0.8	0.9	0.38	0.93	-0.06	0.42		0.97	0.91	0.99	0.94	0.93	0.92	0.97	0.88	0.85	0.92	0.98	0.97	-0.1
Common Stock Shares Outstanding	0.96	0.83	0.92	0.96	0.96	0.97	0.81	0.79	0.2	0.95	-0.07	0.25	0.97		0.94	0.95	0.89	0.95	0.94	0.96	0.77	0.91	0.94	0.97	0.95	-0.28
Non Current Liabilities Total	0.99	0.86	0.91	0.96	0.99	0.95	0.88	0.67	0.02	1.0	-0.13	0.1	0.91	0.94		0.88	0.87	1.0	1.0	0.95	0.66	0.92	1.0	0.97	0.96	-0.41
Inventory	0.92	0.87	0.95	0.97	0.94	0.98	0.79	0.91	0.43	0.89	-0.09	0.45	0.99	0.95	0.88		0.95	0.9	0.89	0.97	0.9	0.86	0.88	0.96	0.95	-0.05
Other Current Assets	0.92	0.94	0.97	0.96	0.93	0.93	0.87	0.89	0.43	0.89	-0.22	0.48	0.94	0.89	0.87	0.95		0.9	0.88	0.96	0.88	0.81	0.88	0.94	0.97	0.01
Other Stockholder Equity	1.0	0.87	0.93	0.98	0.99	0.97	0.88	0.71	0.08	1.0	-0.13	0.15	0.93	0.95	1.0	0.9	0.9		1.0	0.97	0.7	0.92	1.0	0.98	0.97	-0.36
Total Liab	1.0	0.87	0.92	0.97	0.99	0.96	0.89	0.69	0.05	1.0	-0.13	0.12	0.92	0.94	1.0	0.89	0.88	1.0		0.96	0.68	0.92	1.0	0.98	0.96	-0.39
Property Plant And Equipment Gross	0.97	0.93	0.95	0.99	0.98	0.99	0.91	0.81	0.24	0.96	-0.14	0.28	0.97	0.96	0.95	0.97	0.96	0.97	0.96		0.8	0.93	0.96	0.99	0.98	-0.23
Total Current Assets	0.74	0.75	0.89	0.83	0.77	0.8	0.59	1.0	0.76	0.69	-0.11	0.8	0.88	0.77	0.66	0.9	0.88	0.7	0.68	0.8		0.57	0.68	0.8	0.83	0.38
Short Term Debt	0.91	0.8	0.79	0.89	0.9	0.94	0.83	0.58	-0.03	0.92	-0.14	-0.02	0.85	0.91	0.92	0.86	0.81	0.92	0.92	0.93	0.57		0.91	0.91	0.88	-0.49
Intangible Assets	1.0	0.87	0.92	0.97	0.99	0.95	0.89	0.69	0.05	1.0	-0.13	0.12	0.92	0.94	1.0	0.88	0.88	1.0	1.0	0.96	0.68	0.91		0.98	0.96	-0.39
Accounts Payable	0.99	0.91	0.97	1.0	1.0	0.99	0.88	0.81	0.23	0.98	-0.12	0.29	0.98	0.97	0.97	0.96	0.94	0.98	0.98	0.99	0.8	0.91	0.98		0.99	-0.23
Common Stock Total Equity	0.98	0.91	0.98	0.99	0.99	0.98	0.87	0.84	0.29	0.97	-0.15	0.35	0.97	0.95	0.96	0.95	0.97	0.97	0.96	0.98	0.83	0.88	0.96	0.99		-0.16
Short Term Investments	-0.31	-0.11	-0.03	-0.19	-0.27	-0.23	-0.33	0.35	0.87	-0.38	-0.13	0.85	-0.1	-0.28	-0.41	-0.05	0.01	-0.36	-0.39	-0.23	0.38	-0.49	-0.39	-0.23	-0.16

Click cells to compare fundamentals

Neogen Account Relationship Matchups

Neogen fundamental ratios Accounts

	2020	2021	2022	2023	2024	2025 (projected)
Total Assets	920.2M	992.9M	4.6B	4.5B	5.2B	5.5B
Short Long Term Debt Total	1.3M	986.7M	900M	906.2M	1.0B	1.1B
Other Current Liab	26.6M	35.6M	57.2M	48.6M	55.9M	58.7M
Total Current Liabilities	53.6M	77.8M	145.5M	154.3M	177.5M	186.3M
Total Stockholder Equity	840.4M	887.4M	3.1B	3.1B	3.6B	3.8B
Property Plant And Equipment Net	100.5M	110.6M	198.7M	291.9M	335.7M	352.5M
Net Debt	(379.8M)	605.6M	736.8M	735.6M	846.0M	888.3M
Retained Earnings	539.6M	587.9M	565.0M	555.6M	639.0M	670.9M
Cash	381.1M	381.1M	163.2M	170.6M	196.2M	206.0M
Non Current Assets Total	328.7M	366.1M	4.0B	4.0B	4.6B	4.8B
Non Currrent Assets Other	2.0M	2.2M	15.2M	20.2M	23.2M	15.7M
Cash And Short Term Investments	381.1M	381.1M	245.6M	170.9M	196.6M	206.4M
Net Receivables	91.8M	99.7M	153.3M	173.0M	199.0M	208.9M
Common Stock Shares Outstanding	107.1M	108.0M	188.9M	216.5M	249.0M	261.4M
Liabilities And Stockholders Equity	920.2M	992.9M	4.6B	4.5B	5.2B	5.5B
Non Current Liabilities Total	26.2M	27.7M	1.3B	1.3B	1.4B	1.5B
Inventory	100.7M	122.3M	133.8M	189.3M	217.7M	228.5M
Other Current Assets	35.7M	47.5M	53.3M	56.0M	64.4M	67.7M
Other Stockholder Equity	295.0M	310.0M	2.6B	2.6B	3.0B	3.1B
Total Liab	79.8M	105.6M	1.4B	1.4B	1.6B	1.7B
Property Plant And Equipment Gross	102.9M	215.5M	318.9M	432.2M	497.0M	521.9M
Total Current Assets	591.5M	626.8M	585.9M	589.2M	677.6M	711.5M
Accumulated Other Comprehensive Income	(11.4M)	(27.8M)	(33.3M)	(30.0M)	(27.0M)	(25.7M)
Short Term Debt	1.3M	1.4M	3.3M	7.5M	8.7M	9.1M
Intangible Assets	92.3M	107.5M	1.6B	1.5B	1.7B	1.8B
Accounts Payable	23.9M	34.6M	76.7M	83.1M	95.5M	100.3M
Common Stock Total Equity	8.5M	17.2M	17.2M	34.6M	39.8M	41.8M
Short Term Investments	305.5M	336.6M	82.3M	325K	373.8K	355.1K
Common Stock	17.2M	17.2M	34.6M	34.7M	39.9M	37.9M
Other Liab	22.6M	26.2M	27.7M	375.7M	432.1M	453.7M
Other Assets	2.0M	4.8B	15.2M	1.0	1.15	1.09
Good Will	228.3M	255.5M	3.8B	2.1B	2.5B	2.6B
Property Plant Equipment	78.7M	100.5M	110.6M	198.7M	228.6M	240.0M
Current Deferred Revenue	3.4M	5.5M	4.6M	4.6M	5.3M	3.3M
Net Tangible Assets	599.6M	612.1M	887.4M	3.1B	3.6B	3.8B
Retained Earnings Total Equity	478.7M	539.6M	587.9M	565.0M	649.8M	382.8M

Currently Active Assets on Macroaxis

BTC	Bitcoin
TRX	TRON
BNB	Binance Coin
ADA	Cardano
XRP	XRP

When determining whether Neogen is a strong investment it is important to analyze Neogen's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Neogen's future performance. For an informed investment choice regarding Neogen Stock, refer to the following important reports:

How To Invest In Neogen

Details

Is Neogen Stock a good investment?

Details

What is Neogen's Net Worth?

Details

Largest Health Care Equipment & Supplies Companies

View

Largest Health Care Equipment & Services Companies

View

Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Neogen. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons.

For more detail on how to invest in Neogen Stock please use our How to Invest in Neogen guide.

You can also try the Stock Screener module to find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook..

Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Neogen. If investors know Neogen will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Neogen listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Quarterly Earnings Growth

(0.86)

Earnings Share

(2.19)

Revenue Per Share

4.212

Quarterly Revenue Growth

(0.05)

Return On Assets

0.0085

The market value of Neogen is measured differently than its book value, which is the value of Neogen that is recorded on the company's balance sheet. Investors also form their own opinion of Neogen's value that differs from its market value or its book value, called intrinsic value, which is Neogen's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Neogen's market value can be influenced by many factors that don't directly affect Neogen's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Neogen's value and its price as these two are different measures arrived at by different means. Investors typically determine if Neogen is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Neogen's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Neogen Days Sales Outstanding vs Price To Sales Ratio Analysis

Days Sales Outstanding vs Price To Sales Ratio

Days Sales Outstanding vs Price To Sales Ratio Correlation Analysis

Correlation Coefficient

Days Sales Outstanding

Price To Sales Ratio

Neogen fundamental ratios Correlations

Neogen Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Neogen fundamental ratios Accounts

Currently Active Assets on Macroaxis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Total Stockholder Equity	+ 1.0	Total Assets
Non Current Assets Total	+ 1.0	Total Assets
Other Stockholder Equity	+ 1.0	Total Assets
Total Liab	+ 1.0	Total Assets
Intangible Assets	+ 1.0	Total Assets
Accounts Payable	+ 1.0	Total Current Liabilities

Short Term Investments	- 0.49	Short Term Debt
Short Term Investments	- 0.41	Non Current Liabilities Total
Short Term Investments	- 0.39	Intangible Assets
Short Term Investments	- 0.39	Total Liab
Short Term Investments	- 0.38	Non Current Assets Total
Short Term Investments	- 0.36	Other Stockholder Equity